Screening for Critical Congenital Heart Defects with Pulse Oximetry: Medical Aspects

Abstract

The detection of newborn babies with potentially life-threatening, critical congenital heart defects (CCHDs) before they collapse or expire remains an important clinical challenge. The absence of physical signs and the difficulty assessing mild cyanosis means that the newborn baby check misses up to a third of babies. Fetal anomaly ultrasound scanning identifies an increasing proportion, but this screen is operator-dependent and therefore highly variable; although some units report very high detection rates, overall most babies with CCHD are still missed. Pulse oximetry screening (POS) is an additional test that meets the criteria for universal screening. POS increases overall detection of CCHD to over 90% and also identifies babies with noncardiac, hypoxemic conditions (such as congenital pneumonia, early-onset sepsis, and pulmonary hypertension), which are usually included in the false positives. There is a wealth of published data on the POS, both in a research setting and more recently in routine clinical practice, and consideration of POS is becoming increasingly widespread particularly among high-income countries. But a degree of controversy still remains, and debate continues regarding the most appropriate time to screen, the most effective screening pathway, and screening outside the well-baby nursery. So, should all newborn babies be screened with POS, if so, when and where should screening take place, what saturations are acceptable, and which conditions are we trying to identify? This review will look at the available evidence and try to suggest the way forward for those considering its introduction into their clinical practice.

Keywords

newborn infant - pulse oximetry - screening - congenital heart defects

• References

• 1 Ewer AK, Furmston AT, Middleton LJ. , et al. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness. Health Technol Assess 2012; 16 (02) v-xiii , 1–184
• 2 Ewer AK. Review of pulse oximetry screening for critical congenital heart defects in newborn infants. Curr Opin Cardiol 2013; 28 (02) 92-96
• 3 de-Wahl Granelli A, Wennergren M, Sandberg K. , et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ 2009; 338: a3037
• 4 Riede FT, Wörner C, Dähnert I, Möckel A, Kostelka M, Schneider P. Effectiveness of neonatal pulse oximetry screening for detection of critical congenital heart disease in daily clinical routine—results from a prospective multicenter study. Eur J Pediatr 2010; 169 (08) 975-981
• 5 Ewer AK, Middleton LJ, Furmston AT. , et al; PulseOx Study Group. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. Lancet 2011; 378 (9793): 785-794
• 6 Turska Kmieć A, Borszewska Kornacka MK, Błaż W, Kawalec W, Żuk M. Early screening for critical congenital heart defects in asymptomatic newborns in Mazovia province: experience of the POLKARD pulse oximetry programme 2006-2008 in Poland. Kardiol Pol 2012; 70 (04) 370-376
• 7 Zhao QM, Ma XJ, Ge XL. , et al; Neonatal Congenital Heart Disease screening group. Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study. Lancet 2014; 384 (9945): 747-754
• 8 Thangaratinam S, Brown K, Zamora J, Khan KS, Ewer AK. Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis. Lancet 2012; 379 (9835): 2459-2464
• 9 Roberts TE, Barton PM, Auguste PE, Middleton LJ, Furmston AT, Ewer AK. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a cost-effectiveness analysis. Arch Dis Child 2012; 97 (03) 221-226
• 10 Powell R, Pattison HM, Bhoyar A. , et al. Pulse oximetry as a screening test for congenital heart defects in newborn infants: an evaluation of acceptability to mothers. Arch Dis Child Fetal Neonatal Ed 2013; 98 (01) F59-F63
• 11 Mahle WT, Martin GR, Beekman III RH, Morrow WR. ; Section on Cardiology and Cardiac Surgery Executive Committee. Endorsement of Health and Human Services recommendation for pulse oximetry screening for critical congenital heart disease. Pediatrics 2012; 129 (01) 190-192
• 12 de-Wahl Granelli A, Meberg A, Ojala T, Steensberg J, Oskarsson G, Mellander M. Nordic pulse oximetry screening—implementation status and proposal for uniform guidelines. Acta Paediatr 2014; 103 (11) 1136-1142
• 13 Ewer AK. Pulse oximetry screening for critical congenital heart defects in newborn infants: should it be routine?. Arch Dis Child Fetal Neonatal Ed 2014; 99 (01) F93-F95
• 14 Narayen IC, Blom NA, Ewer AK, Vento M, Manzoni P, te Pas AB. Aspects of pulse oximetry screening for critical congenital heart defects: when, how and why?. Arch Dis Child Fetal Neonatal Ed 2016; 101 (02) F162-F167
• 15 Singh A, Rasiah SV, Ewer AK. The impact of routine predischarge pulse oximetry screening in a regional neonatal unit. Arch Dis Child Fetal Neonatal Ed 2014; 99 (04) F297-F302
• 16 Garg LF, Van Naarden Braun K, Knapp MM. , et al. Results from the New Jersey statewide critical congenital heart defects screening program. Pediatrics 2013; 132 (02) e314-e323
• 17 Narayen IC, Blom NA, Bourgonje MS. , et al. Pulse Oximetry Screening for Critical Congenital Heart Disease after Home Birth and Early Discharge. J Pediatr 2016; 170: 188-192.e1
• 18 Cawsey MJ, Noble S, Cross-Sudworth F, Ewer AK. Feasibility of pulse oximetry screening for critical congenital heart defects in homebirths. Arch Dis Child Fetal Neonatal Ed 2016; 101 (04) F349-F351
• 19 Ewer AK, Granelli AD, Manzoni P, Sánchez Luna M, Martin GR. Pulse oximetry screening for congenital heart defects. Lancet 2013; 382 (9895): 856-857